MAIA Biotechnology, Inc. (($MAIA)) announced an update on their ongoing clinical study. MAIA Biotechnology, Inc. has announced a new Phase III ...

Vir Biotechnology, Inc. (($VIR)) announced an update on their ongoing clinical study. Vir Biotechnology, Inc. is conducting a Phase 1 study titled ...

Kaigene Inc., a U.S.-based biotechnology company pioneering next-generation antibody therapeutics for autoimmune disorders, announced today that it has entered into an exclusive global licensing ...

On Monday, April 24, The Biotechnology Study Center of NYU School of Medicine will hold its annual awards symposium to honor three outstanding pioneers in neurobiology and cognition. The Dart/NYU ...

A new study published in Nature Biotechnology shows that stem cell differentiation is linked to cellular structures called ...

New research appearing in the journal Nature Biotechnology answers important questions about the viability of treatments that seek to replace diseased and aged cells in the central nervous system with ...

In the midst of a severe health crisis, Cuba is set to commence a clinical study in the coming days aimed at assessing the ...

Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL), a commercial stage biotechnology company focused on hematologic disorders and cancer, today announced that data from the ongoing Phase 1b study of R2891, a ...

NEW YORK, March 15, 2007 -- On Monday, March 26, The Biotechnology Study Center of NYU School of Medicine will hold its annual awards symposium to honor three outstanding pioneers in biomedical ...

Investors looking for stocks that can produce eye-popping gains in a short time frame often turn toward biotechnology stocks.

Every year, abiotic stress factors such as drought, heat, salinity or high light intensity—combined with unfavorable soil ...